Nothing else comes close to retatrutide for sheer magnitude of weight reduction
Among individual GLP-1 RAs, exenatide exhibited the longest median time to onset at 45 days (IQR = 11213 days), while dulaglutide had the shortest at 7 days (IQR = 29 days), liraglutide at 16 days (IQR = 5.561 days), semaglutide at 12 days (IQR = 445.5 days), and tirzepatide at 10 days (IQR = 235.5 days)
Methods Subjects This study is a secondary analysis of the BeNeDuctus trial
As always, consulting healthcare providers about combination therapies is essential for the best outcomes
The ratio of review articles to original studies is something like two to one in 2026
But these drugs can seriously impact fueling, performance, and recovery